Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Bionova Capital is a healthcare-specialized venture capital firm based in Lisbon, Portugal. Founded in 2015, the firm has dedicated itself to investing in early-stage life science startups across Europe. As of 2024, Bionova Capital has transitioned its team to a new venture capital company named Biovance Capital Partners, following the successful raise of Biovance Capital Fund I. This transition marks a significant evolution in the firm's strategy and operational focus.
Currently, Bionova Capital manages a portfolio of two companies, having shifted its emphasis from new investments to supporting existing portfolio companies. The firm has achieved notable milestones, including two profitable exits, which highlight its effectiveness in the biotech sector. Bionova Capital's commitment to the life sciences sector positions it as a key player in the European venture capital landscape.
Bionova Capital invests in early-stage biotech companies across Europe, specifically targeting the pre-seed, seed, seed+, and Series A stages. The firm has a strong focus on the healthcare sector, particularly innovative life science startups. As of 2024, Bionova Capital has ceased making new investments and is concentrating on managing its existing portfolio, which includes two companies.
The firm has secured two profitable exits, including a notable acquisition of CellmAbs by BioNTech, demonstrating its ability to identify and support high-potential biotech ventures. Bionova Capital's investment strategy emphasizes collaboration with portfolio companies to enhance their growth trajectories while managing existing investments effectively.
Bionova Capital's notable portfolio companies include:
With only two companies in its portfolio, Bionova Capital has focused on maximizing the potential of these investments, particularly in the rapidly evolving biotech sector.
To pitch to Bionova Capital, founders should visit their website at bionovacapital.com. The firm prefers direct applications through their online platform, where detailed information about the startup and its growth strategy should be included. Response times may vary, so patience is advised after submission.
In 2024, Bionova Capital transitioned its team to a new venture capital entity named Biovance Capital Partners. This change follows the successful raise of Biovance Capital Fund I. The firm has also secured two profitable exits, including the notable acquisition of CellmAbs by BioNTech.
What are Bionova Capital's investment criteria?
Bionova Capital focuses on early-stage biotech companies in Europe, particularly those in the pre-seed, seed, seed+, and Series A stages. The firm seeks innovative life science startups with strong growth potential.
How can I apply or pitch to Bionova Capital?
Founders can pitch their ideas by visiting Bionova Capital's website at bionovacapital.com. The firm encourages direct applications through their online platform.
What makes Bionova Capital different from other venture firms?
Bionova Capital specializes in the healthcare sector, particularly biotech, and has a proven track record of successful exits, including the acquisition of CellmAbs by BioNTech. This focus allows them to provide targeted support to their portfolio companies.
What is Bionova Capital's geographic scope?
The firm invests primarily in early-stage biotech companies across Europe, emphasizing innovative life science startups.
What is Bionova Capital's post-investment involvement like?
As of 2024, Bionova Capital is concentrating on managing its existing portfolio rather than pursuing new investments. This focus allows them to provide dedicated support to their current companies.
What is the typical check size for investments?
Bionova Capital typically invests in early-stage companies, with funding amounts varying based on the specific needs of the portfolio companies. For example, Delox received €750,000 as part of its growth strategy.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.